CLINICAL_TRIALS
trial_result
· 2009-09-28
Clinical Trial Update: A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children [Phase 4]
Summary
A Phase 4 pilot trial evaluated a new dosing formulation of polyethylene glycol 3350 for use in constipated children.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Braintree Laboratories | Conditions: Constipation | Phase 4 | Status: COMPLETED